REIIBP is a histone methyltransferase overexpressed in T(4;14) multiple myeloma with oncogenic potential

被引：0
|
作者：
Chooi, Jing Yuan [1 ]
Bin Azaman, Muhammad Irfan [2 ]
Wu, Zhengwei [2 ]
Toh, Sabrina Hui Min [2 ]
Xie, Zhigang [2 ]
Peng, Jianhe [3 ]
Chng, Wee Joo [4 ]
机构：
[1] Natl Univ Singapore, Dept Med, Singapore, Singapore
[2] Canc Sci Inst Singapore, Singapore, Singapore
[3] ASTAR, Expt Therapeut Ctr, Singapore, Singapore
[4] Natl Univ Canc Inst Singapore, Singapore, Singapore
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2019年 / 19卷 / 10期
关键词：
BTK; REIIBP;
D O I：
10.1016/j.clml.2019.09.029
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
OAB-028
引用
收藏
页码：E20 / E20
页数：1
相关论文
共 50 条
  • [21] Translocation t(4; 14) and multiple myeloma : is it a new independent prognostic factor?
    Manier, Salomon
    Leleu, Xavier
    HEMATOLOGIE, 2011, 17 (01): : 17 - 17
  • [22] Diagnostic evaluation of t(4;14) in multiple myeloma and evidence for clonal evolution
    Stewart, A. K.
    Chang, H.
    Trudel, S.
    Anderson, K. C.
    Richardson, P.
    Alsina, M.
    Reece, D.
    Young, S.
    Sable-Hunt, A.
    Li, Z.
    Keats, J.
    Van Wier, S.
    Ahmann, G.
    Price-Troska, T.
    Giusti, K.
    Bergsagel, P. L.
    Chesi, M.
    Fonseca, R.
    LEUKEMIA, 2007, 21 (11) : 2358 - 2359
  • [23] The snoRNA target of t(4;14) in multiple myeloma regulates ribosome biogenesis
    Oliveira, Vanessa
    Mahajan, Nitin
    Bates, Melissa L.
    Tripathi, Chakrapani
    Kim, Kyusik Q.
    Zaher, Hani S.
    Maggi, Leonard B., Jr.
    Tomasson, Michael H.
    FASEB BIOADVANCES, 2019, 1 (07) : 404 - 414
  • [24] Dutcher Bodies in Multiple Myeloma Are Highly Associated With Translocation t(4;14)
    Jiang, Nan
    Qi, Connie
    Chang, Hong
    LABORATORY INVESTIGATION, 2015, 95 : 353A - 353A
  • [25] CHIR-258, a novel, multitargeted tyrosine kinase inhibitor for the potential treatment of t(4;14) multiple myeloma
    Trudel, S
    Li, ZH
    Wei, E
    Wiesmann, M
    Chang, H
    Chen, C
    Reece, D
    Heise, C
    Stewart, AK
    BLOOD, 2005, 105 (07) : 2941 - 2948
  • [26] Longitudinal Analysis of t(11;14) and t(4;14) Genomes Reveals Distinct Evolutionary Trajectories in Multiple Myeloma
    Hudson-Lund, Bethan
    Hughes, Daniel
    Sodi, Isabella
    Foster, Kane
    Lyon, Emma
    Laidler, Annabel
    Rees, Elise
    Galas-Filipowicz, Daria
    Fitzsimons, Evie
    Chavda, Selina
    Rashid, Ambreen
    Lecat, Catherine
    Mehta, Dipal
    Rahman, Jasmin
    Yoon, Jong Won
    Lee, Lydia
    Quezada, Sergio
    Srinivasan, Anandagopal
    Kazeroun, Mohammad
    Ansari-Pour, Naser
    Thakurta, Anjan
    Yong, Kwee
    Cribbs, Adam
    Gooding, Sarah
    Boyle, Eileen
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S163 - S164
  • [27] T(11;14) and t(4;14) translocations correlated with mature lymphoplasmacytoid and immature morphology, respectively, in multiple myeloma
    Garand, R
    Avet-Loiseau, H
    Accard, F
    Moreau, P
    Harousseau, JL
    Bataille, R
    LEUKEMIA, 2003, 17 (10) : 2032 - 2035
  • [28] t(11;14) and t(4;14) translocations correlated with mature lymphoplasmacytoid and immature morphology, respectively, in multiple myeloma
    R Garand
    H Avet-Loiseau
    F Accard
    P Moreau
    J L Harousseau
    R Bataille
    Leukemia, 2003, 17 : 2032 - 2035
  • [29] Targeting Overexpressed IDO on Stromal Cells As a Potential Therapeutic Strategy in Multiple Myeloma
    Ebina, Toru
    Ri, Masaki
    Oshima, Yoshiko
    Nakamura, Tomoyuki
    Marumo, Yoshiaki
    Sasaki, Hirokazu
    Asano, Arisa
    Kinoshita, Shiori
    Suzuki, Tomotaka
    Narita, Tomoko
    Masaki, Ayako
    Sanda, Takaomi
    Komatsu, Hirokazu
    Sakuraba, Hirotake
    Iida, Shinsuke
    BLOOD, 2024, 144
  • [30] Oncogenic histone methyltransferase EZH2: A novel prognostic marker with therapeutic potential in endometrial cancer
    Oki, Shinya
    Sone, Kenbun
    Oda, Katsutoshi
    Hamamoto, Ryuji
    Ikemura, Masako
    Maeda, Daichi
    Takeuchi, Makoto
    Tanikawa, Michihiro
    Mori-Uchino, Mayuyo
    Nagasaka, Kazunori
    Miyasaka, Aki
    Kashiyama, Tomoko
    Ikeda, Yuji
    Arimoto, Takahide
    Kuramoto, Hiroyuki
    Wada-Hiraike, Osamu
    Kawana, Kei
    Fukayama, Masashi
    Osuga, Yutaka
    Fujii, Tomoyuki
    ONCOTARGET, 2017, 8 (25) : 40402 - 40411
12345